Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BHC NYSE:EVT NYSE:MRK BATS:WEED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$4.57+1.0%$5.05$4.33▼$8.69$1.71B0.422.12 million shs1.61 million shsEVTEaton Vance Tax-Advantaged Dividend Income Fund$27.63+0.1%$26.92$23.00▼$27.96N/AN/A104,595 shs55,005 shsMRKMerck & Co., Inc.$127.61+1.1%$120.93$76.66▼$131.74$315.16B0.1910.96 million shs7.79 million shsWEEDRoundhill Cannabis ETF$19.38-1.6%$20.86$11.48▼$31.05$7.27M0.9823,969 shs6,020 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos-3.83%-5.04%-4.84%-20.54%-28.58%EVTEaton Vance Tax-Advantaged Dividend Income Fund+1.22%+0.51%+3.75%+8.27%+14.80%MRKMerck & Co., Inc.+1.50%+4.43%+10.73%+11.88%+59.14%WEEDRoundhill Cannabis ETF+0.97%-4.00%-7.90%-12.99%+65.41%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$4.57+1.0%$5.05$4.33▼$8.69$1.71B0.422.12 million shs1.61 million shsEVTEaton Vance Tax-Advantaged Dividend Income Fund$27.63+0.1%$26.92$23.00▼$27.96N/AN/A104,595 shs55,005 shsMRKMerck & Co., Inc.$127.61+1.1%$120.93$76.66▼$131.74$315.16B0.1910.96 million shs7.79 million shsWEEDRoundhill Cannabis ETF$19.38-1.6%$20.86$11.48▼$31.05$7.27M0.9823,969 shs6,020 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos-3.83%-5.04%-4.84%-20.54%-28.58%EVTEaton Vance Tax-Advantaged Dividend Income Fund+1.22%+0.51%+3.75%+8.27%+14.80%MRKMerck & Co., Inc.+1.50%+4.43%+10.73%+11.88%+59.14%WEEDRoundhill Cannabis ETF+0.97%-4.00%-7.90%-12.99%+65.41%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBHCBausch Health Cos 1.80Reduce$8.0075.25% UpsideEVTEaton Vance Tax-Advantaged Dividend Income Fund 0.00N/AN/AN/AMRKMerck & Co., Inc. 2.70Moderate Buy$133.944.97% UpsideWEEDRoundhill Cannabis ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest WEED, BHC, MRK, HIK, and EVT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026MRKMerck & Co., Inc. JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$135.00 ➝ $140.007/13/2026MRKMerck & Co., Inc. BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$135.00 ➝ $142.007/13/2026MRKMerck & Co., Inc. GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$140.00 ➝ $145.007/9/2026MRKMerck & Co., Inc. Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$112.00 ➝ $113.007/8/2026MRKMerck & Co., Inc. Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$142.007/8/2026MRKMerck & Co., Inc. Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$145.00 ➝ $150.007/6/2026MRKMerck & Co., Inc. Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$120.006/30/2026MRKMerck & Co., Inc. Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$130.00 ➝ $141.006/30/2026MRKMerck & Co., Inc. ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Outperform$136.00 ➝ $155.006/24/2026MRKMerck & Co., Inc. CICC ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$138.005/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)(Data available from 7/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBHCBausch Health Cos$10.27B0.17$7.13 per share0.64$1.02 per share4.48EVTEaton Vance Tax-Advantaged Dividend Income Fund$476.77MN/AN/AN/AN/AN/AMRKMerck & Co., Inc.$65.01B4.85$11.72 per share10.89$21.22 per share6.01WEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBHCBausch Health Cos$157M-$3.24N/A1.25N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)EVTEaton Vance Tax-Advantaged Dividend Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/AMRKMerck & Co., Inc.$18.25B$3.5535.9513.134.9513.59%27.55%10.73%8/4/2026 (Estimated)WEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest WEED, BHC, MRK, HIK, and EVT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2026Q2 2026MRKMerck & Co., Inc.-$0.26N/AN/AN/A$16.40 billionN/A7/29/2026Q2 2026BHCBausch Health Cos$0.96N/AN/AN/A$2.56 billionN/A4/30/2026Q1 2026MRKMerck & Co., Inc.-$1.47-$1.28+$0.19-$1.72$15.85 billion$16.29 billion4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBHCBausch Health CosN/AN/AN/AN/AN/AEVTEaton Vance Tax-Advantaged Dividend Income Fund$1.977.13%N/AN/AN/AMRKMerck & Co., Inc.$3.402.66%+5.75%95.77%14 YearsWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/ALatest WEED, BHC, MRK, HIK, and EVT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/1/2026EVTEaton Vance Tax-Advantaged Dividend Income Fundmonthly$0.16467.26%7/15/20267/15/20267/31/20265/26/2026MRKMerck & Co., Inc.quarterly$0.852.96%6/15/20266/15/20267/8/20266/1/2026EVTEaton Vance Tax-Advantaged Dividend Income Fundmonthly$0.16467.37%6/15/20266/15/20266/30/20265/1/2026EVTEaton Vance Tax-Advantaged Dividend Income Fundmonthly$0.16467.6%5/15/20265/15/20265/29/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBHCBausch Health Cos54.681.320.97EVTEaton Vance Tax-Advantaged Dividend Income FundN/AN/AN/AMRKMerck & Co., Inc.1.021.301.06WEEDRoundhill Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBHCBausch Health Cos78.65%EVTEaton Vance Tax-Advantaged Dividend Income FundN/AMRKMerck & Co., Inc.76.07%WEEDRoundhill Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipBHCBausch Health Cos20.67%EVTEaton Vance Tax-Advantaged Dividend Income FundN/AMRKMerck & Co., Inc.0.17%WEEDRoundhill Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBHCBausch Health Cos20,300374.03 million296.72 millionOptionableEVTEaton Vance Tax-Advantaged Dividend Income FundN/AN/AN/ANot OptionableMRKMerck & Co., Inc.75,0002.47 billion2.47 billionOptionableWEEDRoundhill Cannabis ETFN/A375,000N/ANot OptionableWEED, BHC, MRK, HIK, and EVT HeadlinesRecent News About These CompaniesListed Funds Trust - Roundhill Cannabis ETFJune 24, 2026 | money.usnews.com5 ETFs Up At Least 5% Last Week's Market RoutJune 10, 2026 | zacks.com100 Days Into the Iran War: Winning & Losing ETF AreasJune 8, 2026 | zacks.comUS Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?May 14, 2026 | zacks.comSector ETFs rally in April despite inflation and growth concernsMay 5, 2026 | msn.comBest-Performing ETFs of AprilMay 5, 2026 | zacks.comCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEETF sectors rally on chip surge, cannabis gains, oil jumpApril 29, 2026 | msn.comETF sectors rally as healthcare CapEx growth acceleratesApril 28, 2026 | msn.comSemiconductors, cannabis ETFs lead gains as sector rotation acceleratesApril 28, 2026 | msn.com4 Best-Performing ETF Areas of Last WeekApril 28, 2026 | zacks.comHow to buy marijuana stocks: A beginner’s guideMarch 27, 2026 | msn.comRoundhill Cannabis ETF : WEEDMarch 24, 2026 | 247wallst.comSanta Rally Falls Short: Top ETF Performers of DecemberJanuary 2, 2026 | zacks.comCannabis ETFs surge on Trump's reclassification reviewDecember 18, 2025 | msn.comCannabis ETF (WEED) Hits a New 52-Week HighDecember 17, 2025 | zacks.com6 Top-Performing ETF Areas of Last WeekDecember 17, 2025 | zacks.com5 ETFs to Watch as Restrictions on Marijuana Set to EaseDecember 12, 2025 | etftrends.comECannabis stocks rally on reports Trump plans to reschedule marijuanaDecember 12, 2025 | marketwatch.comWEED: Concentrated, Swap-Heavy, And Too Illiquid For ComfortDecember 8, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Charts That Could Change the Course of Summer TradingBy Thomas Hughes | July 1, 2026Is Apple’s Latest Plunge the Canary in the Coal Mine for Tech Stocks?By Sam Quirke | June 29, 2026Silicon Starvation: Amazon Feasts on Legacy GPUsBy Jeffrey Neal Johnson | July 7, 2026Stacking Chips: The Hidden Supply Shock Fueling IntelBy Jeffrey Neal Johnson | July 8, 2026CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive StocksBy Dan Schmidt | July 15, 2026WEED, BHC, MRK, HIK, and EVT Company DescriptionsBausch Health Cos NYSE:BHC$4.57 +0.05 (+1.00%) Closing price 03:59 PM EasternExtended Trading$4.60 +0.03 (+0.66%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Eaton Vance Tax-Advantaged Dividend Income Fund NYSE:EVT$27.63 +0.04 (+0.14%) Closing price 03:59 PM EasternExtended Trading$27.57 -0.06 (-0.22%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.Merck & Co., Inc. NYSE:MRK$127.61 +1.35 (+1.07%) Closing price 03:59 PM EasternExtended Trading$128.06 +0.45 (+0.36%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.Roundhill Cannabis ETF BATS:WEED$19.38 -0.31 (-1.57%) As of 04:10 PM EasternThe Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Robotaxi Mode Engaged: Tesla Starts Monetizing Its Florida Fleet Insider Moves Are Sending Mixed Signals Across the Tech Sector Boxabl Disrupts Housing With A Tiny Float IPO Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Velo3D Forges a New Reality After Its Sharp Stock Sell-Off Why Apple Could Be the Last One Standing in the Tech Wreck Archer and Anduril Put ACHR Stock on a New Defense Flight Path 3M's Redemption Arc: Can Q2 Earnings Change the Narrative? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
